Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VSTM
#2622
Verastem, Inc.
5.7
2
+1.42%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+1.42%
Mudança mensal
-11.86%
Mudança em 6 meses
-38.49%
Mudança anual
+6.32%
Fechamento anterior
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
Volume
58
Mercados
Ações
Cuidados de saúde
VSTM
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
44.51 M
51.49 M
54.95 M
61.55 M
66.78 M
—
Valuation ratios
Enterprise value
19.9 M
177.37 M
213.77 M
91.09 M
451.93 M
934.16 M
Price to earnings ratio
—
-1.41
-1.79
-1.13
-2
-6.34
Price to sales ratio
8.03
18.46
14.85
63.8
36.92
134.03
Price to cash flow ratio
0.71
1.76
1.88
1.56
3.59
8.8
Price to book ratio
0.65
-6.39
-17.08
-7.89
-7.89
-39.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.19
0.64
0.4
0.13
0.56
1.72
Return on equity %
2.17
2.23
1.61
0.72
6.35
10.91
Return on invested capital %
1 018.92
1 043.91
2 007.91
967.24
602.43
4 621.49
Gross margin %
—
—
100
94.01
97.33
—
Operating margin %
—
—
2 419.17
2 047.92
362.17
—
EBITDA margin %
—
—
—
-2 027.09
-344.72
—
Net margin %
—
—
2 853.4
1 213.57
876.34
—
Liquidity ratios
Quick ratio
—
—
—
3.44
2.55
—
Current ratio
3.23
3.07
3.5
3.46
2.58
12.61
Inventory turnover
—
—
—
0.03
0.2
—
Asset turnover
0
0
0.02
0.01
0.06
0.09
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.24
0.4
0.54
0.38
0.44
1.76
Long term debt to total equity ratio
2.77
1.41
2.2
2.06
5.03
10.71
Per share metrics
Operating cash flow per share
0.59
0.7
0.71
0.44
0.5
2.35
EBIT per share
—
—
—
-0.59
-0.54
—
EBITDA per share
—
—
—
-0.59
-0.53
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.81
2.49
2.17
2.22
1.88
8.76
Net current asset value per share
3
2.66
2.3
2.35
2.11
9.42
Tangible book value per share
0.27
0.81
0.6
0.28
-0.02
1.67
Working capital per share
2.07
1.79
1.64
1.67
1.29
6.4
Book value per share
0.27
0.81
0.6
0.49
0.21
2.11
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Notícias
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley mantém recomendação de Compra para ações da Verastem, com preço-alvo de US$ 16
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem reporta receita de US$ 17,5 milhões no 4º trimestre com tratamento contra câncer
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
Ações da Revolution Medicines disparam mais de 20% com possível aquisição pela AbbVie
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Ações da Verastem se mantêm estáveis enquanto Mizuho reafirma classificação Outperform